Tirzepatide helps curb cravings, making it easier to follow healthier routines
Semaglutide is a weight loss drug that targets the glucagon-like peptide-1 (GLP-1), sold by Novo Nordisk under the brand name Wegovy to treat people with obesity and under Ozempic to treat patients with both type 2 diabetes and obesity
Pngase en contacto con ABLC si presenta vmitos persistentes, dolor abdominal intenso, signos de deshidratacin, sntomas alrgicos, empeoramiento de las reacciones en el lugar de la inyeccin o cualquier otro sntoma que le preocupe
Not Suitable for All Patients: Contraindicated in people with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2)
These compounded formulations from licensed 503A pharmacies may support sustained, affordable therapy if recommended by your provider
You can switch at any time, but it must be done under a doctors supervision.